Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.

Mednet Member

Radiation Oncology · Emory University Afflilated Hospitals & Clinics

I would assume the patient is on a TKI for another malignancy such as RCC, and the question is about treating localized prostate cancer.I ask the medical oncologist for input, and if they agree, I will hold TKI for 3-5 days before and one week after SBRT.This is based on the favorable safety profile...